A primary focus of the UCSF-GIVI CFAR is HIV-related research that is both translational andmultidisciplinary. The research often includes studies in which human subjects are the unit of observationand in whom complex biologic, behavioral, and clinical parameters are measured, often in a longitudinalmanner. A prerequisite of human subjects research is the direct interaction with and exemplarycharacterization of both diseased and non-diseased research subjects. As such, the overall objective of theClinical and Population Sciences Core will be to integrate the population sciences of epidemiology andbiostatistics with the clinical science of HIV medicine to facilitate the interaction with and characterization ofhuman subjects as well the analysis of the data and biological specimens derived from them. Fulfilling thisobjective in turn promotes multidisciplinary collaboration between laboratory-based and human subjectsbasedresearchers and is the sine qua non of translational research. Accordingly, the specific aims of theCore will be to support innovative human subjects-based HIV-related research by:1. Providing expertise in the Clinical and Population Sciences related to HIV/AIDS research via consultationregarding conception of research questions, study design, data management, biostatistical analysis, andinterpretation of data;2. Serving as the resource clearinghouse for CFAR investigators who seek to perform new analyses withavailable data in the many large San Francisco-based and national studies of HIV-infected and at-riskindividuals;3. Managing a unique prospective observational cohort of HIV-infected adults in the contemporary era thatprovides translational researchers with a diverse array of biological specimens from subjects who arewell-characterized in terms of clinical, behavioral, and epidemiologic parameters;4. Providing a platform for the efficient conduct of newly designed prospective human subjects studies;5. Mentoring junior investigators in the conduct of human subjects research.To achieve these aims, the Core will be directed by faculty with a wide range of experience in HIV-relatedresearch as well as methodological expertise in clinical research. In addition, the Core will serve as a link torelated institutional resources at UCSF for human subjects research, including those in the Center for AIDSPrevention Studies, the Division of Biostatistics, and the Training in Clinical Research program. By achievingan economy of scale in its services, the Core will provide resource-efficient, flexible, and timely support toCFAR members as they pursue emerging opportunities in human subjects-based HIV/AIDS research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI027763-16
Application #
7278979
Study Section
Special Emphasis Panel (ZAI1-EC-A (J1))
Project Start
2007-07-01
Project End
2012-08-31
Budget Start
2007-07-01
Budget End
2008-08-31
Support Year
16
Fiscal Year
2007
Total Cost
$404,808
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Ayers, Leona W; Barbachano-Guerrero, Arturo; McAllister, Shane C et al. (2018) Mast Cell Activation and KSHV Infection in Kaposi Sarcoma. Clin Cancer Res 24:5085-5097
Tang, Weiming; Liu, Chuncheng; Cao, Bolin et al. (2018) Receiving HIV Serostatus Disclosure from Partners Before Sex: Results from an Online Survey of Chinese Men Who Have Sex with Men. AIDS Behav 22:3826-3835
Clutton, Genevieve Tyndale; Jones, R Brad (2018) Diverse Impacts of HIV Latency-Reversing Agents on CD8+ T-Cell Function: Implications for HIV Cure. Front Immunol 9:1452
Tamraz, Bani; Huang, Yong; French, Audrey L et al. (2018) A Genome-Wide Association Study Identifies a Candidate Gene Associated With Atazanavir Exposure Measured in Hair. Clin Pharmacol Ther 104:949-956
Jiang, Wei; Luo, Zhenwu; Martin, Lisa et al. (2018) Drug Use is Associated with Anti-CD4 IgG-mediated CD4+ T Cell Death and Poor CD4+ T Cell Recovery in Viral-suppressive HIV-infected Individuals Under Antiretroviral Therapy. Curr HIV Res 16:143-150
Kattah, Michael G; Milush, Jeffrey M; Burt, Trevor et al. (2018) Anti-TNF and thiopurine therapy in pregnant IBD patients does not significantly alter a panel of B-cell and T-cell subsets in 1-year-old infants. Clin Transl Gastroenterol 9:143
Lidofsky, Anna; Holmes, Jacinta A; Feeney, Eoin R et al. (2018) Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection. J Infect Dis 218:1394-1403
El-Sadr, Wafaa M; Goosby, Eric (2018) Building on the HIV platform: tackling the challenge of noncommunicable diseases among persons living with HIV. AIDS 32 Suppl 1:S1-S3
Dunkley, Emma; Ashaba, Scholastic; Burns, Bridget et al. (2018) ""I beg you…breastfeed the baby, things changed"": infant feeding experiences among Ugandan mothers living with HIV in the context of evolving guidelines to prevent postnatal transmission. BMC Public Health 18:188
Streubel, Gundula; Watson, Ariane; Jammula, Sri Ganesh et al. (2018) The H3K36me2 Methyltransferase Nsd1 Demarcates PRC2-Mediated H3K27me2 and H3K27me3 Domains in Embryonic Stem Cells. Mol Cell 70:371-379.e5

Showing the most recent 10 out of 1541 publications